schizandrin b has been researched along with carmustine in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (carmustine) | Trials (carmustine) | Recent Studies (post-2010) (carmustine) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 4,168 | 686 | 540 |
| Protein | Taxonomy | schizandrin b (IC50) | carmustine (IC50) |
|---|---|---|---|
| Glutathione reductase, mitochondrial | Homo sapiens (human) | 8.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, PY; Ko, KM | 1 |
1 other study(ies) available for schizandrin b and carmustine
| Article | Year |
|---|---|
Schisandrin B-induced increase in cellular glutathione level and protection against oxidant injury are mediated by the enhancement of glutathione synthesis and regeneration in AML12 and H9c2 cells.
Topics: Animals; Antifibrinolytic Agents; Antineoplastic Agents, Alkylating; Buthionine Sulfoximine; Carmustine; Cyclooctanes; Cysteine; Cytoprotection; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Glutathione Reductase; L-Lactate Dehydrogenase; Lignans; Mice; Oxidants; Oxidation-Reduction; Polycyclic Compounds; Vitamin K 3 | 2006 |